BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2014
View Archived Issues
Oasmia's paclitaxel formulation shows non-inferiority to Taxol in phase III trial
Read More
Rheumatoid arthritis candidate BI-638683 well tolerated in phase I study
Read More
CKD-L, an HDAC6 inhibitor, may have potential for the treatment of RA
Read More
Phase I results for the rituximab biosimilar PF-05280586
Read More
New CFTR correctors prepared at DiscoveryBiomed
Read More
Biogen Idec discloses novel autotaxin and S1P1 receptor modulators
Read More
Irish and Belgian university researchers report novel HIV-1 RT inhibitors
Read More
Roche prepares agents for neurodegenerative disorders
Read More
Portuguese group designs new agents for tuberculosis
Read More
DARA BioSciences' KRN-5500 receives U.S. orphan drug designation for multiple myeloma
Read More
Takeda to withdraw Omontys NDA and terminate license with Affymax
Read More
Novartis submits BLA to the FDA for meningitis B vaccine candidate
Read More
Merck KGaA and Ono Pharmaceutical terminate license agreement for ceralifimod
Read More
German researchers divulge new agents for cancer
Read More
Collaborative biomarker-driven Lung-MAP trial to test five approaches for NSCLC
Read More
Radiosynthesis and microPET evaluation of F-18 CRF1 receptor PET tracer presented
Read More
Biogen Idec and AbbVie report topline data from phase III daclizumab high-yield process trial
Read More
Can-Fite BioPharma completes enrollment in phase II/III CF-101 trial
Read More
EIB to provide codevelopment funding to UCB
Read More
Mocetinostat receives FDA orphan drug designation in myelodysplastic syndrome
Read More
Caplacizumab achieves clinical proof-of-concept in phase II TITAN study
Read More
FDPA shows potential for imaging bacterial infections in the lung
Read More
Takeda launches Zacras and new Azilva dosage in Japan
Read More
FDA grants fast track status to DNX-2401 for recurrent glioblastoma
Read More
Symplmed files for approval of hypertension combination in the U.S.
Read More
Pfizer files BLA for Neisseria meningitidis serogroup B vaccine
Read More
